Our data demonstrate for the first time that CDCA4-induced autophagy inhibits tumor cell migration and invasion in NSCLC, suggesting that CDCA4 may be a potential therapeutic target for NSCLC. Here, CDCA4 is linked to non-small cell lung carcinoma.